The HIV epidemic in South Africa has several distinctive features; """"""""explosive"""""""" spread, predominance in women at younger ages, and very high prevalence with no sign of a 'saturation' plateau. As accompanying morbidity and now mortality rise, design of effective prevention and treatment calls for better understanding of the unfolding epidemiologic pattern. Community-level epidemiological, demographic and social data are necessary as the basis for assessing prevention and/or therapeutic approaches. We therefore propose to monitor epidemic trends in a rural community by gender, age and relevant social factors such as occupation and education at four levels: population rates of HIV prevalence and incidence; morbidity and health service impact; mortality; and the social/behavioral impact of AIDS mortality. HIV prevalence will be measured in patients attending antenatal, family planning, sexually transmitted diseases and tuberculosis clinics at two major health centers in a rural South Africa district. Each of these risk groups will be sampled for two months each year in order to obtain adequate numbers of or age-specific rates. The sensitive/less sensitive assay, which was recently validated with South African seroconvertors, will be used to determine the incidence rates in these groups. HIV-associated morbidity will be documented in clinic registers specifically devised for this purpose. These data will then elucidate the case mix at the clinics and provide an indication of the changing burden on AIDS in primary health care services. Data on deaths due to AIDS will be collected from several sources, including death certificates, cemetery records, undertaker records and from local traditional leaders. Trends in mortality and the changing age-specific mortality rates will be documented together with more detailed information obtained from verbal autopsies. Household members experiencing a death due to AIDS will be compared to household members experiencing a death due to any other cause, to determine if the AIDS death led to the adoption of HIV riskreducing behavior. Taken together these data will produce a comprehensive profile of the evolving HIV/AIDS epidemic in a rural community in South Africa.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI051794-01
Application #
6547953
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2002-01-01
Project End
2006-12-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Kwazulu-Natal
Department
Type
DUNS #
637360244
City
Durban
State
Country
South Africa
Zip Code
3630
Sheward, Daniel J; Marais, Jinny; Bekker, Valerie et al. (2018) HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth. Cell Host Microbe 24:593-599.e3
Johnson, Erik L; Doria-Rose, Nicole A; Gorman, Jason et al. (2018) Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation. Nat Commun 9:4136
Garrett, Nigel; Norman, Emily; Leask, Kerry et al. (2018) Acceptability of Early Antiretroviral Therapy Among South African Women. AIDS Behav 22:1018-1024
Setliff, Ian; McDonnell, Wyatt J; Raju, Nagarajan et al. (2018) Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection. Cell Host Microbe 23:845-854.e6
Harichund, Charlene; Moshabela, M (2018) Acceptability of HIV Self-Testing in Sub-Saharan Africa: Scoping Study. AIDS Behav 22:560-568
Naidoo, Kogieleum; Yende-Zuma, Nonhlanhla; Augustine, Stanton (2018) A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection. Infect Dis Poverty 7:35
Moosa, Yumna; Tanko, Ramla F; Ramsuran, Veron et al. (2018) Case report: mechanisms of HIV elite control in two African women. BMC Infect Dis 18:54
Scheepers, Cathrine; Chowdhury, Sudipa; Wright, W Shea et al. (2017) Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses. AIDS 31:2199-2209
Ngandu, Nobubelo K; Carlson, Jonathan M; Chopera, Denis R et al. (2017) Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide. J Acquir Immune Defic Syndr 76:43-47
Anthony, Colin; York, Talita; Bekker, Valerie et al. (2017) Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope. J Virol 91:

Showing the most recent 10 out of 188 publications